GSK's Belantamab Among Drugs Seeking EU Approval Nod

Second Time Around For GSK's BCMA-Targeting Therapy

Question Mark
Companies will find out this week whether their new drugs are likely to be approved across the EU • Source: Shutterstock

More from Product Reviews

More from Pink Sheet